I-Mab Site 4005

Tokyo

1 studies enrolling now · 1 studies all time

What they study most

Advanced Cancer, Esophageal Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Carcinoma, Metastatic Cancer, Solid Tumor

Studies at this site

• Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) — Recruiting now